New device aims to make lung biopsies safer and more precise

NCT ID NCT06046001

Completed Knowledge-focused Sponsor: Philips Clinical & Medical Affairs Global Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a new navigation device called AirWaze, designed to help doctors perform lung biopsies using CT scans. 37 adults with lung lesions underwent a bronchoscopy procedure with the device. The main goals were to see if the device was easy to use and if it could accurately confirm that the biopsy tool reached the right spot, potentially using a lower-dose CT scan.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AirWaze device (navigation software for bronchoscopy)
What this could lead to: If successful, this device could make lung biopsies more accurate and reduce radiation exposure during the procedure.
What could go wrong: This is a small, completed usability study with only 37 participants. It does not test whether the device improves patient outcomes, only that it is easy to use and accurate for confirming tool placement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG DISEASES

Contacts and locations

Locations

Radboudumc

Nijmegen, Gelderland, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.